Advertisement
Screener

Lineage Cell Therapeutics, Inc. (LCTX) Graph

LCTX Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Revenue $1.07M; Revenue including tax $943.00K; Cost of revenue (m); Research and development $4.77M.
  • 2026-03-31: Revenue $1.73M; Revenue including tax $1.57M; Cost of revenue (m); Research and development $4.23M.
  • 2025-12-31: Revenue $6.61M*; Revenue including tax $6.26M*; Cost of revenue (m); Research and development $8.24M*.
  • 2025-09-30: Revenue $3.68M; Revenue including tax $3.54M; Cost of revenue (m); Research and development $3.27M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$1.07M$943.00K(m)$4.77M(m)(m)$1.48M
2026-03-31$1.73M$1.57M(m)$4.23M(m)(m)-$4.81M
2025-12-31$6.61M*$6.26M*(m)$8.24M*(m)(m)$851.00K*
2025-09-30$3.68M$3.54M(m)$3.27M(m)(m)-$29.78M
2025-06-30$2.77M$2.53M(m)$3.11M(m)(m)-$30.46M
2025-03-31$1.50M$1.27M$36.00K$3.11M(m)(m)-$4.14M
2024-12-31(m)(m)$154.00K*(m)(m)(m)(m)
2024-09-30$3.78M$3.39M$38.00K$3.17M(m)$0.00-$3.03M
2024-06-30$1.41M$1.10M$44.00K$2.87M(m)$0.00-$5.76M
2024-03-31$1.44M$1.19M$98.00K$3.01M(m)$0.00-$6.54M
2023-12-31$2.09M(m)(m)(m)$8.19M(m)-$4.78M
2023-09-30$1.25M$957.00K$169.00K$3.74M$7.78M$0.00-$7.11M
2023-06-30$3.23M$2.87M$127.00K$3.87M$8.12M$0.00-$5.23M
2023-03-31$2.39M$2.12M$119.00K$4.18M$8.91M-$1.80M-$4.37M
2022-12-31$1.92M(m)(m)(m)$8.45M(m)-$6.35M
2022-09-30$3.00M$2.59M$235.00K$3.59M$8.01M$541.00K-$6.07M
2022-06-30$4.55M$4.15M$215.00K$3.30M$8.57M(m)-$6.76M
2022-03-31$5.24M$4.87M$176.00K$2.99M$11.46M(m)-$7.09M
2021-12-31$1.17M(m)(m)(m)$29.20M(m)-$28.99M
2021-09-30$2.27M$293.00K$985.00K$2.81M$8.13M-$1.01M-$7.82M
2021-06-30$512.00K$213.00K$125.00K$2.93M$7.47M(m)-$4.79M
2021-03-31$391.00K$391.00K$112.00K$3.39M$7.33M(m)-$1.42M
2020-12-31$355.00K$355.00K(m)(m)$6.12M(m)$2.03M
2020-09-30$571.00K$571.00K$102.00K$3.57M$7.19M(m)-$7.76M
2020-06-30$386.00K$386.00K$75.00K$2.81M$6.71M(m)-$6.52M
2020-03-31$514.00K$514.00K$94.00K$3.34M$7.86M(m)-$8.40M
2019-12-31(m)$1.24M(m)(m)$7.99M(m)-$4.48M
2019-09-30(m)$567.00K$114.00K$4.27M$8.88M$1.00M-$16.50M
2019-06-30(m)$779.00K$107.00K$5.24M$11.49M(m)-$30.03M
2019-03-31(m)$928.00K$68.00K$4.96M$13.62M$4.38M$39.31M
2018-12-31(m)$758.00K(m)(m)$10.81M(m)-$44.95M
2018-09-30$982.00K$982.00K$35.00K$4.88M$11.30M(m)$66.72M
2018-06-30$2.55M$2.55M$106.00K$6.36M$11.59M(m)-$4.21M
2018-03-31$701.00K$701.00K$109.00K$5.93M$12.78M(m)-$63.55M
2017-12-31$945.00K$945.00K(m)(m)$10.51M(m)-$71.93M
2017-09-30$1.69M$1.64M$52.00K$6.56M$11.15M$0.00$14.32M
2017-06-30$381.00K$376.00K$5.00K$6.27M$10.69M(m)-$11.65M
2017-03-31$390.00K$333.00K$57.00K$6.49M$11.60M(m)$49.29M
2016-12-31$1.10M(m)(m)(m)$12.36M(m)-$4.95M
2016-09-30$1.44M(m)$58.00K$6.42M$11.00M(m)$31.20M
2016-06-30$1.17M(m)$95.00K$8.94M$15.57M(m)$24.55M
2016-03-31$1.85M(m)$225.00K$13.73M$25.61M(m)-$17.11M
2015-12-31$1.31M(m)(m)(m)$23.01M(m)-$13.51M
2015-09-30$1.87M(m)$432.00K$11.43M$18.98M(m)-$13.63M
2015-06-30$1.75M(m)$260.00K$9.06M$15.24M(m)-$9.69M
2015-03-31$1.00M(m)$264.00K$9.32M$14.50M(m)-$10.17M
2014-12-31$1.67M(m)(m)(m)$16.07M(m)-$10.57M
2014-09-30$960.00K(m)$231.00K$8.84M$13.10M-$2.31M-$8.27M
2014-06-30$855.00K(m)$252.00K$9.08M$13.92M-$1.51M-$9.52M
2014-03-31$935.00K(m)$131.91K$8.41M$12.07M-$1.35M-$8.10M
2013-12-31$1.67M(m)(m)(m)$13.50M(m)-$19.61M
2013-09-30$507.38K(m)$206.68K$6.44M$10.71M$0.00-$9.00M
2013-06-30$1.04M(m)$180.81K$5.53M$9.15M$0.00-$7.55M
2013-03-31$431.72K(m)$182.75K$5.40M$8.81M$0.00-$7.72M
2012-12-31$1.07M(m)(m)(m)$8.12M(m)-$6.04M
2012-09-30$833.82K(m)$169.73K$4.55M$6.78M(m)-$4.96M
2012-06-30$949.75K(m)$83.92K$4.62M$7.03M(m)-$5.46M
2012-03-31$631.95K(m)$20.27K$4.18M$6.55M(m)-$4.97M
2011-12-31$1.63M(m)(m)(m)$7.08M(m)-$5.14M
2011-09-30$1.14M(m)$18.52K$3.49M$5.38M(m)-$3.74M
2011-06-30$755.55K(m)$24.82K$3.33M$5.74M(m)-$4.28M
2011-03-31$824.63K(m)(m)$2.95M$4.85M(m)-$3.36M
2010-09-30$815.28K(m)(m)-$1.81M-$3.27M(m)-$4.67M
2010-06-30$680.28K(m)(m)-$1.43M$3.00M(m)-$2.26M

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$2.79M$2.52M(m)$9.01M(m)(m)-$3.33M
2025-06-30$4.27M$3.80M(m)$6.22M(m)(m)-$34.60M
2024-06-30$2.85M$2.29M$142.00K$5.88M(m)$0.00-$12.30M
2023-06-30$5.61M$4.99M$246.00K$8.06M$17.03M-$1.80M-$9.60M
2022-06-30$9.79M$9.01M$391.00K$6.29M$20.03M(m)-$13.85M
2021-06-30$903.00K$213.00K$237.00K$6.33M$14.80M(m)-$6.20M
2020-06-30$900.00K$900.00K$169.00K$6.14M$14.57M(m)-$14.92M
2019-06-30(m)$1.71M$175.00K$10.20M$25.11M$5.60M$9.28M
2018-06-30$3.25M$3.25M$215.00K$12.29M-$24.26M(m)-$67.76M
2017-06-30$771.00K(m)$62.00K$12.77M$22.29M(m)$37.64M
2016-06-30$3.34M(m)$320.00K$22.67M$41.18M(m)$7.44M
2015-06-30$3.27M(m)$525.00K$18.38M$29.75M(m)-$19.86M
2014-06-30$2.17M(m)$383.00K$17.47M$25.97M-$2.86M-$17.61M
2013-06-30$1.82M(m)$363.56K$10.98M$17.98M$0.00-$15.28M
2012-06-30$1.69M(m)$105.50K$8.77M$13.58M(m)-$10.43M
2011-06-30$1.61M(m)$24.83K$6.28M$10.59M(m)-$7.64M
2010-06-30$1.45M(m)(m)-$2.59M$5.09M(m)-$3.55M

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$7.95M$7.35M(m)$9.49M(m)(m)-$64.38M
2024-09-30$6.63M$5.67M$180.00K$9.05M(m)$0.00-$15.34M
2023-09-30$6.86M$5.95M$415.00K$11.80M$24.81M-$1.80M-$16.71M
2022-09-30$12.79M$11.61M$626.00K$9.88M$28.04M$541.00K-$19.92M
2021-09-30$3.17M$506.00K$1.22M$9.14M$22.92M-$1.18M-$14.03M
2020-09-30$1.47M$1.47M$271.00K$9.71M$21.77M(m)-$22.68M
2019-09-30(m)$2.27M$289.00K$14.46M$33.99M$6.60M-$7.23M
2018-09-30$4.23M$4.23M$250.00K$17.18M$35.56M(m)-$1.04M
2017-09-30$2.46M(m)$114.00K$19.33M$33.44M$0.00$51.96M
2016-09-30$4.84M(m)$378.00K$29.09M$52.18M(m)$38.65M
2015-09-30$5.58M(m)$957.00K$29.82M$48.73M(m)-$33.57M
2014-09-30$3.37M(m)$614.00K$26.27M$39.03M-$5.17M-$25.83M
2013-09-30$2.54M(m)$570.24K$17.39M$28.66M$0.00-$24.27M
2012-09-30$2.69M(m)$273.92K$13.32M$20.36M(m)-$15.39M
2011-09-30$2.78M(m)$58.81K$9.76M$15.95M(m)-$11.15M
2010-09-30$2.26M(m)(m)-$4.40M-$8.36M(m)-$8.22M

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$14.56M$13.61M(m)$17.73M(m)-$5.28M-$63.53M
2024-12-31$9.50M$8.15M$334.00K$12.47M(m)$0.00-$18.61M
2023-12-31$8.95M$7.59M$671.00K$15.71M$33.01M-$1.80M-$21.49M
2022-12-31$14.70M$13.37M$728.00K$13.99M$36.49M$541.00K-$26.27M
2021-12-31$4.34M$1.12M$1.43M$33.91M$52.13M(m)-$43.02M
2020-12-31$1.83M$1.83M$385.00K$12.32M$27.89M-$1.24M-$20.65M
2019-12-31$3.52M$3.52M$412.00K$17.95M$41.98M-$7.41M-$11.71M
2018-12-31$4.99M$4.99M$302.00K$20.95M$46.48M$346.00K-$45.99M
2017-12-31$3.46M$3.46M$168.00K$24.02M$43.95M(m)-$19.98M
2016-12-31$5.92M(m)$358.00K$36.11M$64.53M(m)$33.57M
2015-12-31$7.04M(m)$1.11M$42.60M$71.74M(m)-$46.99M
2014-12-31$5.24M(m)$837.00K$37.53M$55.09M(m)-$36.41M
2013-12-31$4.43M(m)$793.00K$26.61M$59.63M(m)-$43.88M
2012-12-31$3.92M(m)$434.27K$18.12M$28.48M(m)-$21.43M
2011-12-31$4.43M(m)$79.40K$13.70M$23.04M(m)-$16.52M
2010-12-31$3.71M(m)$27.72K$8.19M$13.53M(m)-$11.18M
2009-12-31$1.93M(m)(m)-$3.18M$5.45M(m)-$5.14M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51